Table 2

The presence [number (percentage)] of individual MMPs and TIMPs in different stages of gastric cancer

Tumour stage
1a (n=5)1b (n=17)2 (n=43)3a (n=8)4 (n=1)Total
MMP-1
 Strong1 (20)8 (47)17 (40)1 (13)1(100)28 (38)
 Weak1 (20)5 (29)16 (37)4 (50)026 (35)
 Absent3 (60)4 (24)10 (23)3 (37)020 (27)
 Total5 (100)17 (100)43 (100)8 (100)1 (100)74 (100)
MMP-2
 Strong3 (60)13 (76)39 (90)7 (87)1 (100)63 (86)
 Weak1 (20)3 (18)2 (5)1 (13)07 (9)
 Absent1 (20)1 (6)2 (5)004 (5)
 Total5 (100)17 (100)43 (100)8 (100)1 (100)74 (100)
MMP-3
 Strong003 (7)003 (4)
 Weak04 (24)9 (21)4 (50)017 (23)
 Absent5 (100)13 (76)31 (72)4 (50)1 (100)54 (73)
 Total5 (100)17 (100)43 (100)8 (100)1 (100)74 (100)
MMP-9
 Strong2 (40)7 (41)19 (44)2 (25)030 (41)
 Weak2 (40)7 (41)15 (35)3 (37.5)1 (100)28 (38)
 Absent1 (20)3 (18)9 (21)3 (37.5)016 (21)
 Total5 (100)17 (100)43 (100)8 (100)1 (100)74 (100)
TIMP-1
 Strong1 (20)2 (12)7 (16)0010 (14)
 Weak2 (40)6 (35)12 (28)0020 (27)
 Absent2 (40)9 (53)24 (56)8 (100)1 (100)44 (59)
 Total5 (100)17 (100)43 (100)8 (100)1 (100)74 (100)
TIMP-2
 Strong1 (20)1 (6)10 (23)0012 (16)
 Weak1 (20)7 (41)16 (37)5 (62.5)1 (100)30 (41)
 Absent3 (60)9 (53)17 (40)3 (37.5)032 (43)
 Total5 (100)17 (100)43 (100)8 (100)1 (100)74 (100)
  • Results are expressed as number (%).